Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
02/2001
02/15/2001WO2000064874A3 Heterosubstituted pyridine derivatives as pde 4 inhibitors
02/15/2001WO2000054759A3 Lxr modulators
02/15/2001DE19936780A1 Neue Antagonisten von Integrinrezeptoren New antagonists of integrin
02/15/2001CA2382759A1 Agent for the remedy of neural damage having a nitrogen-containing compound as the active ingredient
02/15/2001CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof
02/15/2001CA2379977A1 Novel integrin receptor antagonists
02/15/2001CA2379322A1 Torsemide polymorphs
02/15/2001CA2378310A1 Arylsulfonamido-substituted hydroxamic acid derivatives
02/15/2001CA2378241A1 Benzanilides as potassium channel openers
02/14/2001EP1076053A1 3-arylphenyl sulfide derivatives and insecticides and miticides
02/14/2001EP1075481A1 Monomeric, oligomeric and polymeric knoevenagel condensation products
02/14/2001EP1075469A1 Piperazine derivatives and process for the preparation thereof
02/14/2001CN1284057A Adamantane derivatives
02/13/2001US6187950 Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological
02/13/2001US6187944 A phenyl acrylonitrile compounds useful as active ingredients of an insecticide, a miticide, a nematicide, a soil pesticide, a fungicide and a marine antifouling agent
02/13/2001US6187943 Catalyzing the reaction in the presence of a metal oxide catalyst containing vanadium and/or molybdenum in a fluidized bed
02/13/2001US6187812 For controlling animal pests or harmful fungi; (e,e,e)-2-methoxyimino-2-(2'-(1?-methyl, 1?-(1?'-ethoxyiminoethyl))iminooxymethyl)phenylacetic acid monomethylamide, for example
02/13/2001US6187792 Compounds with analgesic effect
02/13/2001US6187393 For liquid crystal displays
02/13/2001US6187222 Electrooptical liquid crystal system
02/13/2001CA2147808C Acetylenic biaromatic compounds containing an adamantyl group; pharmaceutical and cosmetic compositions containing them and uses thereof
02/12/2001CA2280249A1 Vanadium compounds as anti-angiogenics and as inhibitors of endothelin production
02/08/2001WO2001009127A1 Benzoxazine derivatives and their therapeutic use
02/08/2001WO2001009120A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
02/08/2001WO2001009119A2 Chemokine receptor antagonists
02/08/2001WO2001009108A1 Process for making n-alkyl bis(thiazolyl)sulfenimides
02/08/2001WO2001009104A1 Trifluoromethylpyri(mi)dine carboxamides
02/08/2001WO2001009098A1 N-(benzylsulfonyl)picolinamide derivatives, process for the preparation thereof and herbicides
02/08/2001WO2001009097A1 Cyclic amine derivatives for the treatment of neurological diseases
02/08/2001WO2001009096A2 Potassium channel openers
02/08/2001WO2001009095A1 Mutilin derivatives and their use as antibacterials
02/08/2001WO2001009088A1 Urea derivatives as inhibitors of ccr-3 receptor
02/08/2001WO2001009076A2 Retinoids for the treatment of emphysema
02/08/2001WO2001008685A1 Acyclic and cyclic amine derivatives
02/08/2001WO2001008682A2 Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats
02/08/2001WO2001008673A1 Calcilytic compounds
02/08/2001WO2001008672A2 Glucamine compounds for treating hepatitis virus infections
02/08/2001WO2000044717A3 Synthesis of oligoketides
02/08/2001DE19937494A1 New carboxylic acid amides are Factor Xa and serine protease inhibitors, useful for the treatment and prevention of thrombotic disorders, tumors and fibrin-dependent inflammation
02/08/2001CA2380081A1 Calcilytic compounds
02/08/2001CA2380032A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
02/08/2001CA2379993A1 Acyclic and cyclic amine derivatives
02/08/2001CA2378936A1 Potassium channel openers
02/08/2001CA2362785A1 Glucamine compounds for treating hepatitis virus infections
02/07/2001EP1074544A1 Process for production of 3-(3-pyridyl)-1-propanol derivatives
02/07/2001EP1073658A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
02/07/2001EP1073641A2 New substituted amides, their production and their use
02/07/2001EP1073640A1 Naphthalene derivatives, their production and use
02/07/2001EP1073638A1 Heterocyclically substituted amides, their production and their use
02/07/2001EP1073637A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases
02/07/2001EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
02/07/2001EP1073632A1 Substituted benzamides, their production and their use as cysteine protease inhibitors
02/07/2001EP1073631A1 New substituted amides, their production and their use
02/07/2001EP1073627A1 Processes for preparing pesticidal intermediates
02/07/2001EP1073626A1 Azine used as fungicides
02/07/2001EP1073624A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors
02/07/2001EP1073431A1 Use of nmda antagonists for treatment of irritable bowel syndrome
02/07/2001EP1073430A1 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
02/07/2001CN1283196A N-pheny lamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
02/07/2001CN1283189A Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
02/07/2001CN1283188A Bisulfate salt of HIV protease inhibitor
02/07/2001CN1283181A Substituted beta-alanines
02/07/2001CN1283180A Inhibition of raf kinase using symmerical and unsymmerical substituted diphenyl ureas
02/07/2001CN1061646C Substituted benzylurea derivatives and medicine containing the same
02/06/2001US6184425 Process for preparing fluorine-containing compounds
02/06/2001US6184384 Dechlorination of pyridines in acidic, zinc-containing mediums
02/06/2001US6184383 Useful for a photographic coupler, or as an intermediate in a variety of organic synthesis.
02/06/2001US6184237 Substituted pyridine compounds and methods of use
02/06/2001US6183815 Protective coatings for corrosion, oil and water resistance
02/06/2001CA2147807C Bicyclic-aromatic compounds; pharmaceutical and cosmetic compositions containing them and uses
02/03/2001CA2314746A1 Use of flupirtin for amelioration of pains in the degenerative joint diseases of dogs and cats
02/02/2001CA2314458A1 Process for production of 3-(3-pyridyl)-1-propanol derivatives
02/01/2001WO2001007533A1 Electron-driven chirality switches
02/01/2001WO2001007497A2 Performance of energy storage devices: potential areas for dendritic chemistry involvement
02/01/2001WO2001007411A1 Biarylurea derivatives
02/01/2001WO2001007410A1 Process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl) phenyl] ethanone
02/01/2001WO2001007403A1 Naphthyl-substituted sulfonamides
02/01/2001WO2001007402A1 Antiviral agents
02/01/2001WO2001007401A1 Tricyclic compounds and drug compositions containing the same
02/01/2001WO2001007020A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
02/01/2001WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia
02/01/2001WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
02/01/2001DE19935219A1 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicaments containing these compounds, their use and production
02/01/2001CA2393110A1 Electron-driven chirality switches
02/01/2001CA2380389A1 Biarylurea derivatives
01/2001
01/31/2001EP1072587A1 Sulfonamide derivatives and drugs containing the same as the active ingredient
01/31/2001EP1072584A1 Amine derivative fixed to resin and method for synthesizing beta-aminocarbonyl compound in a solid phase
01/31/2001EP1071745A2 Process for synthesizing cox-2 inhibitors
01/31/2001EP1071660A1 N-sulphonyl and n-sulphinyl phenylglycinamide
01/31/2001EP1071648A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
01/31/2001CN1282326A Anilide derivative, production and use thereof
01/31/2001CN1282319A Aminobutanoic acid derivatives
01/31/2001CN1282251A Method and material for treating and preventing mucosal tissue inflammation
01/31/2001CN1061347C 抗真菌剂 Antifungal agents
01/31/2001CN1061339C Novel sulfonamide inhibitors of aspartyl protease
01/30/2001US6180815 Compounds which abrogate hemagglutinin-mediated fusion of virus-host membranes; treating influenza
01/30/2001US6180795 Process for making N-alkyl bis(thiazolyl)sulfenimides
01/30/2001US6180787 Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
01/30/2001US6180759 Process for the preparation of azacycloalkylakanoyl pseudotetrapeptides
01/30/2001US6180676 Guanylhydrazones and their use to treat inflammatory conditions